On #InternationalRareDiseaseDay 2026, we join the global movement to recognise 300 million people worldwide living with a rare disease.

At Orphalan, our mission is clear: to develop and deliver treatments for rare diseases that improve patients’ lives through research, education, awareness, and support.

We are proud to once again partner with #RunForRare, with 43 colleagues across Europe, China, and the U.S. taking part in the challenge from 23 February to 2 March. Together, we run to raise awareness, strengthen our global community, and demonstrate our solidarity with patients and families affected by rare diseases. The photos shared today reflect the commitment and energy of our teams worldwide.

As we continue to grow, our purpose remains unchanged: to serve patients living with rare diseases, wherever they are, and whatever their journey may be.